DOV-102677 is a psychoactive drug being developed by Merck and is currently in clinical trials. It is a triple reuptake inhibitor, or serotonin-norepinephrine-dopamine reuptake inhibitor. It is the-enantiomer of DOV-216,303, and its-enantiomer is DOV-21,947.
Molecular Weight:
228.12
CAS Number:
[410074-75-8]
Formula:
C11H11Cl2N
Target:
Others
T69275
* VAT and and shipping costs not included. Errors and price changes excepted